BioInvent International AB (publ) (STO:BINV)
Sweden · Delayed Price · Currency is SEK 4.300
-1.130 (-20.81%)
Nov 2, 2026, 5:29 PM CET
STO:BINV Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 224.56 | 356.17 | 434.83 | 259.55 | 515.05 | 910.76 |
Short-Term Investments | - | 236.58 | 432.33 | 809.15 | 502.43 | 172.07 |
Cash & Short-Term Investments | 224.56 | 592.75 | 867.16 | 1,069 | 1,017 | 1,083 |
Cash Growth | -67.48% | -31.64% | -18.86% | 5.03% | -6.04% | 48.48% |
Accounts Receivable | 34.68 | 1.69 | 8.27 | 11.93 | 15.78 | 0.37 |
Other Receivables | - | 16.72 | 22.98 | 27.76 | 24.19 | 12.54 |
Receivables | 34.68 | 18.4 | 31.25 | 39.69 | 39.97 | 12.91 |
Inventory | 9.74 | 12.29 | 10.97 | 11.84 | 11.51 | 16.85 |
Prepaid Expenses | - | 14.25 | 33.84 | 13.04 | 15.11 | 3.43 |
Total Current Assets | 268.98 | 637.69 | 943.21 | 1,133 | 1,084 | 1,116 |
Property, Plant & Equipment | 39.08 | 33.51 | 46.02 | 52.66 | 52.01 | 49.08 |
Long-Term Investments | - | - | - | 214.25 | 576.14 | 282.21 |
Total Assets | 308.06 | 671.2 | 989.24 | 1,400 | 1,712 | 1,447 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | - | 52.34 | 49.1 | 29.19 | 41.35 | 19.72 |
Accrued Expenses | - | 28.14 | 24.78 | 25.01 | 22.91 | 16.89 |
Current Portion of Leases | 8.42 | 7.37 | 9.2 | 8.71 | 8.19 | 6.84 |
Other Current Liabilities | 87.79 | 24.58 | 12.13 | 13.01 | 14.88 | 15.35 |
Total Current Liabilities | 96.21 | 112.43 | 95.21 | 75.92 | 87.32 | 58.79 |
Long-Term Leases | 10.91 | 1.16 | 8.22 | 14.54 | 18.77 | 21.53 |
Total Liabilities | 107.12 | 113.59 | 103.42 | 90.45 | 106.09 | 80.32 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 13.2 | 13.16 | 13.16 | 13.16 | 12.99 | 11.69 |
Additional Paid-In Capital | - | 3,759 | 3,759 | 3,759 | 3,728 | 3,450 |
Retained Earnings | - | -3,215 | -2,887 | -2,463 | -2,135 | -2,095 |
Comprehensive Income & Other | 187.74 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity | 200.94 | 557.62 | 885.82 | 1,310 | 1,606 | 1,367 |
Total Liabilities & Equity | 308.06 | 671.2 | 989.24 | 1,400 | 1,712 | 1,447 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 19.33 | 8.53 | 17.41 | 23.24 | 26.96 | 28.37 |
Net Cash (Debt) | 205.24 | 584.22 | 849.75 | 1,045 | 990.52 | 1,054 |
Net Cash Growth | -69.81% | -31.25% | -18.72% | 5.55% | -6.06% | 46.93% |
Net Cash Per Share | 3.12 | 8.88 | 12.91 | 15.90 | 16.10 | 19.47 |
Filing Date Shares Outstanding | 65.8 | 65.8 | 65.8 | 65.8 | 65.8 | 58.47 |
Total Common Shares Outstanding | 65.8 | 65.8 | 65.8 | 65.8 | 64.97 | 58.47 |
Working Capital | 172.77 | 525.26 | 848.01 | 1,057 | 996.74 | 1,057 |
Book Value Per Share | 3.05 | 8.47 | 13.46 | 19.90 | 24.72 | 23.38 |
Tangible Book Value | 200.94 | 557.62 | 885.82 | 1,310 | 1,606 | 1,367 |
Tangible Book Value Per Share | 3.05 | 8.47 | 13.46 | 19.90 | 24.72 | 23.38 |
Buildings | - | 16.62 | 16.51 | 16.25 | 16.25 | 15.84 |
Machinery | - | 99.21 | 97.76 | 92.67 | 84.31 | 73.79 |